Schedule 13G ownership disclosure
ARNO THERAPEUTICS INC
Security class unavailable · CUSIP: 042564104
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,385,400
- Percent of class
- 6.7900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-16-000082
- Form type
- SC 13G
- Filer
- Arno Therapeutics, Inc
- CIK
- CIK 1195116
- Filed
- Jan 05, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership